Pharmaceuticals Global On demand · 24-48h

Global Cellulose Derivative Excipient Market Strategic Research Report

Global Cellulose Derivative Excipient Market Strategic Resea…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Cellulose Derivative Excipient Market
$2.11B2025
11%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Microcrystalline Cellulose MCC, Hypromellose HPMC, Hydroxypropyl Cellulose HPC, Others

By Application: Sustained Release Preparation, Tablet, Capsule

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: International Flavors & Fragrances, JRS Pharma, Shin-Etsu Chemical Co., Ltd., Ashland, Asahi Kasei, Mingtai, Huzhou Zhanwang, Sunhere Pharmaceutical Excipients, Shandong HEAD, Lotte Chemicals, Shandong Liaocheng E HUA Pharmaceutical Co., Ltd, Yingkou AODA Pharmaceuticals, Accent Microcell, Qufu TIANLI MEDICAL Supplements, C & J Chemical Industries Co., Ltd.

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 122 pages
Market size 2025
$2.11B
Billion USD
Forecast CAGR
11%
2025-2032
Forecast 2032
$4.4B
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Cellulose Derivative Excipient market size is predicted to grow from US$ 2,110 million in 2025 to US$ 4,355 million in 2032; it is expected to grow at a CAGR of 11.0% from 2026 to 2032.

The key manufacturers of Cellulose Derivative Excipient in the world are International Flavors&Fragrances, JRS Pharma, Shin Etsu Chemical Co., Ltd., Ashland, Asahi Kasei, Mingtai, Huzhou Zhanwang, and Shanhe Pharmaceutical, among which the top three manufacturers have a market share of nearly 60%. Currently, the largest producer is Huzhou Zhanwang. The production of cellulose derivative excipients worldwide is mainly concentrated in regions such as North America, Europe, China, and Japan, with the top three production regions accounting for over 70% of the market share. Currently, North America is the largest production region. In terms of its product types, the growth rate of microcrystalline cellulose MCC is relatively fast, with hypromellose HPMC accounting for the highest market share, exceeding 50%, followed by products such as microcrystalline cellulose MCC and hydroxypropyl cellulose HPC. In terms of its application, tablet are the largest application field, with a market share of nearly 40%, followed by sustained release preparation and capsule.

This report presents a comprehensive overview of the global Cellulose Derivative Excipient market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Microcrystalline Cellulose MCC
  • Hypromellose HPMC
  • Hydroxypropyl Cellulose HPC
  • Others

Segment by Application

  • Sustained Release Preparation
  • Tablet
  • Capsule

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Cellulose Derivative Excipient market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Sustained Release Preparation, Tablet, Capsule evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Cellulose Derivative Excipient Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 11%
Regional growth momentum
Market share by segment
Key metrics
Base value
$2.11B
2025
Forecast
$4.4B
2032
CAGR
11%
2025–2032
Regions
5
global
Key companies
International Flavors & FragrancesJRS PharmaShin-Etsu Chemical Co., Ltd.AshlandAsahi KaseiMingtaiHuzhou ZhanwangSunhere Pharmaceutical Excipients
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Microcrystalline Cellulose MCCHypromellose HPMCHydroxypropyl Cellulose HPCOthers
By Application
Sustained Release PreparationTabletCapsule

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Microcrystalline Cellulose MCC
  • 3.1.3 Hypromellose HPMC
  • 3.1.4 Hydroxypropyl Cellulose HPC
  • 3.1.5 Others
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Sustained Release Preparation
  • 4.1.3 Tablet
  • 4.1.4 Capsule
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 International Flavors & Fragrances
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 JRS Pharma
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Shin-Etsu Chemical Co., Ltd.
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Ashland
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Asahi Kasei
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Mingtai
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Huzhou Zhanwang
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Sunhere Pharmaceutical Excipients
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Shandong HEAD
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Lotte Chemicals
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Yingkou AODA Pharmaceuticals
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Accent Microcell
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Qufu TIANLI MEDICAL Supplements
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 C & J Chemical Industries Co., Ltd.
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Cellulose Derivative Excipient market size?
The global Cellulose Derivative Excipient market is estimated at US$ 2.11 billion in 2025 (base year) and is projected to reach US$ 4.36 billion by 2032.
What growth rate is expected for the Cellulose Derivative Excipient market through 2032?
The market is expected to grow at a CAGR of 11.0% from 2026 to 2032, expanding from US$ 2.11 billion in 2025 to US$ 4.36 billion in 2032, roughly 2.1 times its base-year value.
How is Cellulose Derivative Excipient defined?
The key manufacturers of Cellulose Derivative Excipient in the world are International Flavors&Fragrances, JRS Pharma, Shin Etsu Chemical Co., Ltd., Ashland, Asahi Kasei, Mingtai, Huzhou Zhanwang, and Shanhe Pharmaceutical, among which the top three manufacturers have a market share of nearly 60%. Currently, the largest producer is Huzhou Zhanwang.
What are the main segments of the Cellulose Derivative Excipient market by type?
By type, the market is segmented into Microcrystalline Cellulose MCC, Hypromellose HPMC, Hydroxypropyl Cellulose HPC and Others.
Which applications drive demand in the Cellulose Derivative Excipient market?
Key applications covered include Sustained Release Preparation, Tablet and Capsule.
Who are the key players in the Cellulose Derivative Excipient market?
Key players profiled include International Flavors & Fragrances, JRS Pharma, Shin-Etsu Chemical Co., Ashland, Asahi Kasei, Mingtai, Huzhou Zhanwang and Sunhere Pharmaceutical Excipients, among 15 companies covered in total.
Which regions and countries are covered for Cellulose Derivative Excipient?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Cellulose Derivative Excipient market report?
The report is intended for manufacturers and solution providers, distributors and end users in Sustained Release Preparation, Tablet and Capsule, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Cellulose Derivative Excipient market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.